Skip to main content
. 2020 Mar 28;46(5):854–887. doi: 10.1007/s00134-020-06022-5
Recommendation

45. In critically ill adults with COVID-19, we suggest against the routine use of standard intravenous immunoglobulins (IVIG).

Weak recommendation, low-quality evidence.